• 1
    Al-Hussain TO, Dababo MA (2009) Posterior fossa tumor in a 2 year-old girl. Brain Pathol 19:343346.
  • 2
    Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB et al (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756760.
  • 3
    Bonnin JM, Rubinstein LJ (1989) Astroblastomas: a pathological study of 23 tumors, with a postoperative follow-up in 13 patients. Neurosurgery 25:613.
  • 4
    Cabello A, Madero S, Castresana A, Diaz-Lobato R (1991) Astroblastoma: electron microscopy and immunohistochemical findings: case report. Surg Neurol 35:116121.
  • 5
    Dahlstrand J, Collins VP, Lendahl U (1992) Expression of the class VI intermediate filament nestin in human central nervous system tumors. Cancer Res 52:53345341.
  • 6
    Dunham C, Sugo E, Tobias V, Wills E, Perry A (2007) Embryonal tumor with abundant neuropil and true rosettes (ETANTR): report of a case with prominent neurocytic differentiation. J Neurooncol 84:9198.
  • 7
    Eberhart CG (2011) Molecular diagnostics in embryonal brain tumors. Brain Pathol 21:96104.
  • 8
    Eberhart CG, Brat DJ, Cohen KJ, Burger PC (2000) Pediatric neuroblastic brain tumors containing abundant neuropil and true rosettes. Pediatr Dev Pathol 3:346352.
  • 9
    Fan X, Mikolaenko I, Elhassan I, Ni X, Wang Y, Ball D et al (2004) Notch1 and notch2 have opposite effects on embryonal brain tumor growth. Cancer Res 64:77877793.
  • 10
    Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gul N et al (2010) NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells 28:516.
  • 11
    Ferri Niguez B, Martinez-Lage JF, Almagro MJ, Fuster JL, Serrano C, Torroba MA et al (2010) Embryonal tumor with abundant neuropil and true rosettes (ETANTR): a new distinctive variety of pediatric PNET: a case-based update. Childs Nerv Syst 26:10031008.
  • 12
    Gowda KK, Gupta K, Kapoor R, Vasishta RK (2012) Nuclear expression of beta-catenin and stem cell markers as potential prognostic indicators in medulloblastoma. Neurol India 60:487494.
  • 13
    Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M et al (2003) Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A 100:1517815183.
  • 14
    Jackson EL, Garcia-Verdugo JM, Gil-Perotin S, Roy M, Quinones-Hinojosa A, VandenBerg S et al (2006) PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron 51:187199.
  • 15
    Korshunov A, Remke M, Gessi M, Ryzhova M, Hielscher T, Witt H et al (2010) Focal genomic amplification at 19q13.42 comprises a powerful diagnostic marker for embryonal tumors with ependymoblastic rosettes. Acta Neuropathol 120:253260.
  • 16
    Korshunov A, Remke M, Werft W, Benner A, Ryzhova M, Witt H et al (2010) Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification. J Clin Oncol 28:30543060.
  • 17
    Korshunov A, Witt H, Hielscher T, Benner A, Remke M, Ryzhova M et al (2010) Molecular staging of intracranial ependymoma in children and adults. J Clin Oncol 28:31823190.
  • 18
    Krupkova O, Jr, Loja T, Redova M, Neradil J, Zitterbart K, Sterba J et al (2011) Analysis of nuclear nestin localization in cell lines derived from neurogenic tumors. Tumour Biol 32:631639.
  • 19
    La Spina M, Pizzolitto S, Skrap M, Nocerino A, Russo G, Di Cataldo A et al (2006) Embryonal tumor with abundant neuropil and true rosettes. A new entity or only variations of a parent neoplasms (PNETs)? This is the dilemma. J Neurooncol 78:317320.
  • 20
    Lamont JM, McManamy CS, Pearson AD, Clifford SC, Ellison DW (2004) Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients. Clin Cancer Res 10:54825493.
  • 21
    Li M, Lee KF, Lu Y, Clarke I, Shih D, Eberhart C et al (2009) Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors. Cancer Cell 16:533546.
  • 22
    Lim DA, Cha S, Mayo MC, Chen MH, Keles E, VandenBerg S et al (2007) Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro Oncol 9:424429.
  • 23
    Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97109.
  • 24
    Louis DN , Ohgaki H , Wiestler OD , Webster KC (eds) (2007) WHO Classification of Tumours of the Central Nervous System, 4th edn. International Agency for Research on Cancer: Lyon.
  • 25
    Ma HI, Chiou SH, Hueng DY, Tai LK, Huang PI, Kao CL et al (2011) Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation. J Neurosurg 114:651662.
  • 26
    Manjila S, Ray A, Hu Y, Cai DX, Cohen ML, Cohen AR (2011) Embryonal tumors with abundant neuropil and true rosettes: 2 illustrative cases and a review of the literature. Neurosurg Focus 30:E2.
  • 27
    Mizrak D, Brittan M, Alison M (2008) CD133: molecule of the moment. J Pathol 214:39.
  • 28
    Panagiotakos G, Tabar V (2007) Brain tumor stem cells. Curr Neurol Neurosci Rep 7:215220.
  • 29
    Pfister S, Remke M, Toedt G, Werft W, Benner A, Mendrzyk F et al (2007) Supratentorial primitive neuroectodermal tumors of the central nervous system frequently harbor deletions of the CDKN2A locus and other genomic aberrations distinct from medulloblastomas. Genes Chromosomes Cancer 46:839851.
  • 30
    Pfister S, Remke M, Castoldi M, Bai AH, Muckenthaler MU, Kulozik A et al (2009) Novel genomic amplification targeting the microRNA cluster at 19q13.42 in a pediatric embryonal tumor with abundant neuropil and true rosettes. Acta Neuropathol 117:457464.
  • 31
    Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105111.
  • 32
    Russo C, Pellarin M, Tingby O, Bollen AW, Lamborn KR, Mohapatra G et al (1999) Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors. Cancer 86:331339.
  • 33
    Son MJ, Woolard K, Nam DH, Lee J, Fine HA (2009) SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell 4:440452.
  • 34
    Tong QS, Zheng LD, Tang ST, Ruan QL, Liu Y, Li SW et al (2008) Expression and clinical significance of stem cell marker CD133 in human neuroblastoma. World J Pediatr 4:5862.
  • 35
    Wang Y, Chu SG, Xiong J, Cheng HX, Chen H, Yao XH (2011) Embryonal tumor with abundant neuropil and true rosettes (ETANTR) with a focal amplification at chromosome 19q13.42 locus: further evidence of two new instances in China. Neuropathology 31:639647.